Phase 3 study of Nalbuphine®ER in patients with uremic pruritus
Latest Information Update: 09 Nov 2016
At a glance
- Drugs Nalbuphine (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- 09 Nov 2016 New trial record
- 13 Oct 2016 According to Trevi Therapeutics media release, this study is intended to start in 2017.